Leafly Holdings Stock (NASDAQ:LFLY), Trade Ideas

Leafly Holdings

Leafly Holdings Inc operates an online cannabis information resource platform. It offers cannabis retailers and brands subscription-based marketplace listings that provide its cannabis audience with information, reviews, menus, and ordering and delivery options through legal retailers.

NY LAWSUIT

Cannabis

Government

News

Regulations

Legal

LFLY

Judge strikes down some NY cannabis regulations, citing unfair restrictions on advertising.

New York Supreme Court Judge Strikes Down Some Cannabis Regulations, Unsettling Industry Stakeholders

Penny Stocks

Small Cap

Intraday Update

Markets

Movers

Trading Ideas

AAPL

BNAI

CJET

CRGX

FOUR

FRES

GETY

GOEV

GOOGL

GWAV

HGAS

IMRX

JOAN

LEGH

LIDR

LOGI

NBTX

NVEI

NYCB

QBTS

QRTEB

RBLX

RETO

RILY

SAIC

SMMT

SOND

SWIM

SWIN

TCBP

TLRY

TSVT

VERB

VERI

WAVD

WKSP

WLDS

XRTX

Shares of  Science Applications International Corporation (NYSE: SAIC) fell sharply during Monday’s session after the company reported financial fourth-quarter EPS below estimates.

Why Science Applications International Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Monday&#39;s Mid-Day Session

Exclusives

CRLBF

CURALEAF HLDGS INC by Curaleaf Hldgs Inc.

CURLF

CWBHF

GLASF

GTBIF

MAPS

TCNNF

VRNOF

CPA and business advisory firm MGO unveiled its fifth annual &#34;Cannabis 50&#34; list. This list celebrates the impactful contributions of companies, organizations and individuals in the cannabis and hemp sectors over the past five years.

Cannabis 50 List: Impactful Companies, Organizations And Individuals In The Last 5 Years, Per MGO

Leafly Holdings Inc

Aurora Cannabis Inc.&nbsp;captured investor attention with a dramatic 38% increase in options trading and a significant 18.2% surge in stock price in a single trading day.
These movements underscore a robust financial period for the company, which reported quarterly revenues of $53.34 million, surpassing expectations by nearly 16%.
<h2>Stock Performance Overview</h2>
On a notable Tuesday, Aurora Cannabis Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/acb#NASDAQ">ACB</a>) witnessed a surge in options trading activity. The cannabis company observed investors purchasing 24,073 call options, a stark 38% increase <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/04/38149371/nasdaq-listed-marijuana-stocks-tilray-canopy-aurora-rally-whats-behind-the-surge">over the typical volume </a>of 17,462 options.&nbsp;
On the same trading day, Aurora saw its <a href="https://www.marketbeat.com/instant-alerts/nasdaq-acb-options-data-report-2024-04-23/">stock price surge</a> by 18.2%, climbing $1.14 to close at $7.42. Trading volume for the day dramatically increased to 9,331,051 shares, nearly doubling the average volume of 4,809,986 shares.
The company demonstrated a low debt-to-equity ratio of 0.14, and currently, boasts a market capitalization of $404.69 million, despite a negative price-to-earnings ratio of -2.56.&nbsp;
This means that despite its negative earnings metrics, Aurora maintains a strong liquidity position and a stable financial structure, which could reassure investors about its ability to manage short-term <a href="https://www.benzinga.com/markets/cannabis/24/03/37422276/aurora-cannabis-bounces-back-debt-paid-growth-ahead">obligations and debts</a>.
The company&#39;s significant market capitalization also reflects a level of investor confidence in its potential for <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/02/37353256/all-you-need-to-know-about-the-german-marijuana-market-changes-size-and-leading-pla">long-term growth</a> and recovery.
<h3>Recent Stock Dynamics</h3>
Later in the week, ACB shares experienced a dip, opening at $7.20 on Thursday, reflecting the stock&#39;s ongoing volatility.
Despite reaching a 52-week high of $11.50 and a low of $2.84, Aurora has maintained relatively stable long-term price trends, with a 50-day moving average of $4.51 and a 200-day moving average of $4.56.
This pattern underscores the stock&#39;s fluctuating yet consistent performance within the market.
<h3>Financial Health And Earnings Insight</h3>
Aurora Cannabis disclosed its earnings on February 8th, reporting a quarterly loss of $0.20 per share, which fell short of the consensus estimates predicting a $0.10 loss per share.
However, the company&#39;s revenue reached $53.34 million, exceeding the expected $45.94 million. Despite these revenue gains, Aurora Cannabis continues to wrestle with a substantial negative net margin of 48.82% and a negative return on equity of 23.27%.
The company&rsquo;s financial structure remains solid, underscored by <a href="http://www.marketbeat.com/instant-alerts/nasdaq-acb-options-data-report-2024-04-23/">indicators of&nbsp;strong liquidity</a>. The combination of underperforming profit metrics and surpassing revenue forecasts suggests that while Aurora is effective at generating sales, it faces challenges in translating these revenues into net profits.
The substantial negative net margin and return on equity highlight ongoing operational or financial inefficiencies. However, the solid liquidity ratios reassure stakeholders of the company&#39;s ability to sustain its<a href="https://www.benzinga.com/markets/cannabis/24/03/37848787/aurora-cannabis-earns-coveted-gmp-certification-for-australian-market-heres-what-it-means"> operations</a> and potentially invest in <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/03/37896976/cannabis-stocks-set-to-dominate-germanys-new-market-a-surge-in-demand-meets-establi">strategic initiatives</a> to improve profitability.
<h3>Institutional Investor Engagement</h3>
In recent months, Aurora Cannabis has seen significant <a href="https://www.benzinga.com/markets/cannabis/24/03/37755041/cannabis-stocks-jump-on-news-that-dea-may-soon-undertake-marijuana-reform">shifts</a> in institutional investment. MMCAP International Inc. SPC established a new position worth approximately $4.659 million.
Cambria Investment Management L.P. notably increased its holdings by 115.5%, while Mirae Asset Global Investments Co. Ltd. expanded its stake by 6.3%.
Similarly, Vontobel Holding Ltd. boosted its investment by 67.5%, holding 125,304 shares valued at $73,000.
These movements highlight <a href="https://www.benzinga.com/markets/cannabis/24/03/37568032/aurora-cannabis-exec-says-company-well-positioned-in-germany-will-push-for-expansion-of-medical-">growing confidence</a> among major financial players, with institutional investors now owning 47.63% of the company&rsquo;s stock, as <a href="https://www.etfdailynews.com/2024/04/25/investors-purchase-large-volume-of-aurora-cannabis-call-options-nasdaqacb/">reported</a> by ETF Daily News.
Photo: AI-Generated Image.&nbsp;

Analyst Color

Options

Retail Sales

Analyst Ratings

Investors Shuffle Stock Positions In Aurora Cannabis: Beyond Earnings, Liquidity Looks Appealing

Continuing her commitment to criminal justice reform,&nbsp;businesswoman and celeb&nbsp;Kim Kardashian met with <a href="https://www.benzinga.com/markets/cannabis/24/03/37760731/vp-kamala-harris-urges-dea-to-reschedule-cannabis-as-quickly-as-possible-calls-prohibition-absur">Vice President Kamala Harris </a>to discuss new strategies for addressing <a href="https://www.benzinga.com/cannabis">marijuana policies</a>.
The meeting, which took place at the White House, highlighted President Joe Biden&#39;s <a href="https://www.benzinga.com/markets/cannabis/24/04/38412810/president-biden-pardons-commutes-16-non-violent-drug-offenders-cannabis-prisoners-excluded">recent use of clemency powers</a>, particularly for non-violent&nbsp;offenses.
<h3>Presidential Clemency</h3>
Recently, Biden pardoned 11 individuals and commuted the sentences of five others, all convicted for non-violent drug-related activities, underlining a shift towards more lenient sentences under current laws. This move aligns with his broader efforts to rectify past judicial discrepancies.
The <a href="https://apnews.com/article/kamala-harris-kardashian-criminal-justice-reform-biden-d34ae7fb30b1fe78326dafad230611d0">event</a> was marked by heartfelt stories from those pardoned, sharing tales of newfound opportunities and personal growth post-incarceration. Kardashian, reflecting on the gathering, emphasized the importance of amplifying such stories to inspire others in similar situations.
<h3>Historical Advocacy</h3>
Kardashian has been a vocal advocate for criminal justice reform, notably influencing policy during the Trump administration alongside Jared Kushner.
Her efforts have led to significant legal changes and individual pardons, including the high-profile case of Alice Marie Johnson in 2018.
<h3>Loan Restrictions</h3>
VP Harris announced a new rule from the Small Business Administration, aimed at easing loan restrictions for individuals with criminal records. This policy intends to facilitate reintegration and <a href="https://www.npr.org/2024/04/25/1247183807/kim-kardashian-white-house-criminal-justice-reform">provide second chances</a>.
&quot;Reducing and eliminating that restriction is going to mean a lot in terms of second chances and the opportunity for people to excel,&quot; Harris <a href="https://www.npr.org/2024/04/25/1247183807/kim-kardashian-white-house-criminal-justice-reform">said</a>.
The Biden administration has consistently worked towards reducing penalties for drug offenses, notably expanding a sweeping pardon for those convicted of simple <a href="https://www.benzinga.com/markets/cannabis/24/04/37988501/59-of-americans-support-right-to-grow-legal-cannabis-at-home-new-survey-finds">marijuana</a> possession&mdash;a move that resonates strongly with many voters, particularly young and minority groups.
This collaboration between Kardashian and Harris not only underscores the ongoing reform efforts but also showcases the influential role celebrities can play in shaping public policy and social justice.
Photo via Wikimedia Commons

Entertainment

Politics

General

Kim Kardashian And VP Harris Discuss Cannabis Justice Reform And 'Second Chances' At The White House

Citigroup analyst Atif Malik maintains Silicon Laboratories (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLAB#NASDAQ">SLAB</a>) with a Neutral and lowers the price target from $137 to $120.

Price Target

SLAB

Citigroup Maintains Neutral on Silicon Laboratories, Lowers Price Target to $120

In a compelling showcase of how sports figures leverage their platforms beyond the field, former NFL athletes <a href="https://www.benzinga.com/general/sports/24/04/38358885/joique-bell-to-discuss-journey-from-rookie-to-prominent-nfl-running-back-at-benzinga-draft-event">Joique Bell</a> and<a href="https://www.benzinga.com/markets/cannabis/24/03/37797148/former-nfl-legends-bring-top-cannabis-strains-to-boston-with-launch-of-primitiv"> Rob Sims</a> shared their philanthropic journeys today (April 25) during the <a href="https://www.youtube.com/watch?v=93htkUYdGNc">Benzinga Sports Business Titans Draft</a> event in Detroit. 
The panel, adjacent to the NFL Draft at Campus Martius, highlighted the transformative impact athletes can have in their communities post-retirement.
<h1 class="wp-block-heading">Athletes Turned Philanthropists</h1>
Moderated by Rachel Decker, president of Detroit Philanthropy, the conversation delved into the personal motivations behind the athletes&#8217; commitments to giving back. 
Bell, a Michigan native and former Detroit Lion, emphasized the influence of his upbringing on his charitable efforts. 
&#8220;Growing up, being involved in community service was ingrained in me by my parents,&#8221; Bell said. He discussed his focus on literacy and education through his foundation, which aims to improve reading levels among students within a short period significantly.
Sims, who transitioned from the gridiron to various business and charitable endeavors, highlighted his strategic approach to philanthropy. 
&#8220;It&#8217;s about making an impact with the resources we have, ensuring our efforts genuinely help those in need,&#8221; Sims stated. His involvement with local organizations such as Detroit PAL and the Children&#8217;s Center demonstrates his commitment to youth and community health.
<h1 class="wp-block-heading">Impact And Influence&nbsp;</h1>
The discussion also covered the athletes&#8217; strategies for selecting and managing philanthropic engagements. 
Both Bell and Sims stressed the importance of aligning with causes that reflect their values and where they can make a meaningful difference. Bell shared his rigorous approach to vetting organizations before partnering with them, ensuring alignment with his goals to support community development.
<h1 class="wp-block-heading">Advice For The Next Generation&nbsp;</h1>
As the event drew the attention of young athletes and aspiring philanthropists, Bell and Sims offered advice on starting and running charitable foundations. 
&#8220;Understand the work that goes into managing a foundation; it&#8217;s akin to running a business,&#8221; Sims advised. Bell echoed this sentiment, emphasizing the importance of commitment and genuine passion for the cause.
<h1 class="wp-block-heading">Legacy Beyond The Field&nbsp;</h1>
Reflecting on their legacies, both athletes expressed a desire to be remembered for their contributions off the field as much as their achievements on it. 
&#8220;It&#8217;s not just about the sports; it&#8217;s about using our platform to make a lasting impact,&#8221; said Bell.
Photo by Dustin Blitchok.

Sports

Events

Game Changers: Ex-NFL Players Talk Philanthropy For Today And Next-Gen At Benzinga Titans Draft Event

Citigroup analyst Ronald Josey maintains Lithia Motors (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LAD#NYSE">LAD</a>) with a Neutral and lowers the price target from $320 to $280.

Citigroup Maintains Neutral on Lithia Motors, Lowers Price Target to $280

Citigroup analyst David Lebovitz maintains Biomarin Pharmaceutical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BMRN#NASDAQ">BMRN</a>) with a Neutral and lowers the price target from $94 to $91.

BMRN

Citigroup Maintains Neutral on Biomarin Pharmaceutical, Lowers Price Target to $91

Citigroup analyst Michelle Fang maintains New Oriental Education (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EDU#NYSE">EDU</a>) with a Buy and raises the price target from $66 to $127.

New Oriental Education & Technology Group

Citigroup Maintains Buy on New Oriental Education, Raises Price Target to $127

Citigroup analyst Andrew Kaplowitz maintains Fortive (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FTV#NYSE">FTV</a>) with a Buy and lowers the price target from $101 to $98.

Citigroup Maintains Buy on Fortive, Lowers Price Target to $98

Microsoft Sees FY24 Productivity And Business Processes Revenue $19.9B-$20.2B; Intelligent Cloud Revenue $28.4B-$28.7B; More Personal Computing Revenue $15.2B-$15.6B; Cost Of Revenue COGS Of $19.6B-$19.8B; Operating Expenses Of $17.15B-$17.25B; Effective Tax Rate ~18%

Guidance

MSFT

Microsoft Sees FY24 Productivity And Business Processes Revenue $19.9B-$20.2B; Intelligent Cloud Revenue $28.4B-$28.7B; More Personal Computing Revenue $15.2B-$15.6B; Cost Of Revenue COGS Of $19.6B-$19.8B; Operating Expenses Of $17.15B-$17.25B; Effective Tax Rate ~18%

Citigroup analyst Anthony Pettinari maintains Packaging Corp of America (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PKG#NYSE">PKG</a>) with a Neutral and lowers the price target from $183 to $181.

Citigroup Maintains Neutral on Packaging Corp of America, Lowers Price Target to $181

Citigroup analyst Christopher Allen maintains Virtu Finl (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VIRT#NASDAQ">VIRT</a>) with a Buy and raises the price target from $22.5 to $24.5.

VIRT

Citigroup Maintains Buy on Virtu Finl, Raises Price Target to $24.5

Citigroup analyst Thomas Palmer maintains Bunge Global (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BG#NYSE">BG</a>) with a Buy and raises the price target from $117 to $122.

Citigroup Maintains Buy on Bunge Global, Raises Price Target to $122

Citigroup analyst Fatima Boolani maintains Fastly (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FSLY#NYSE">FSLY</a>) with a Neutral and lowers the price target from $20 to $15.

FSLY

Citigroup Maintains Neutral on Fastly, Lowers Price Target to $15

Citigroup analyst Fatima Boolani maintains Akamai Techs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AKAM#NASDAQ">AKAM</a>) with a Neutral and lowers the price target from $140 to $117.

AKAM

Citigroup Maintains Neutral on Akamai Techs, Lowers Price Target to $117

Citigroup analyst Joanne Wuensch maintains Boston Scientific (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BSX#NYSE">BSX</a>) with a Buy and raises the price target from $79 to $85.

Citigroup Maintains Buy on Boston Scientific, Raises Price Target to $85

Citigroup analyst Patrick Cunningham maintains Sherwin-Williams (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SHW#NYSE">SHW</a>) with a Buy and lowers the price target from $390 to $370.

Citigroup Maintains Buy on Sherwin-Williams, Lowers Price Target to $370

Citigroup analyst Jon Tower maintains Chipotle Mexican Grill (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CMG#NYSE">CMG</a>) with a Buy and raises the price target from $3358 to $3369.

Citigroup Maintains Buy on Chipotle Mexican Grill, Raises Price Target to $3369

Citigroup analyst Jason Gursky maintains Boeing (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BA#NYSE">BA</a>) with a Buy and lowers the price target from $252 to $224.

Citigroup Maintains Buy on Boeing, Lowers Price Target to $224

Citigroup analyst Andrew Kaplowitz maintains GE Aero (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GE#NYSE">GE</a>) with a Buy and raises the price target from $120.43 to $186.

Citigroup Maintains Buy on GE Aero, Raises Price Target to $186

Citigroup analyst Jason Gursky maintains General Dynamics (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GD#NYSE">GD</a>) with a Buy and raises the price target from $300 to $320.

Citigroup Maintains Buy on General Dynamics, Raises Price Target to $320

A rating of 71 puts Leafly Holdings Inc (LFLY) near the top of the Consumer Defensive sector according to InvestorsObserver.Leafly Holdings Inc's score of 71 means that it ranks higher than 71% of stocks in the sector. In addition, its overall score of 38 ranks it higher than 38% of all stocks. LFLY has an Overall Score of

Will Leafly Holdings Inc (LFLY) Beat the Rest of the Stocks in the Consumer Defensive Sector?

Leafly Holdings GAAP EPS of -$0.22 beats by $1.19, revenue of $9.75M beats by $0.26M

Leafly Holdings, Inc. (LFLY) has shared an announcement. Michael Blue stepped down from his roles on Leafly Holdings, Inc.'s Board, prompting the a...

Leafly Holdings Announces Board Reshuffle and New Chair

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Leafly Holdings (NASDAQ:<a href="https://investorplace.com/stock-quotes/lfly-stock-quote/">LFLY</a>) just reported results for the fourth quarter of 2023.<ul><li>Leafly Holdings reported earnings per share of -22 cents. This was above the analyst estimate for EPS of -$1.45.</li><li>The company reported revenue of $9.75 million.</li><li>This was 2.69% better than the analyst estimate for revenue of $9.49 million.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/earning-results/2024/03/lfly-stock-earnings-leafly-holdings-for-q4-of-2023/">LFLY Stock Earnings: Leafly Holdings Beats EPS, Beats Revenue for Q4 2023</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

LFLY Stock Earnings: Leafly Holdings Beats EPS, Beats Revenue for Q4 2023

Leafly Holdings Inc (LFLY) Q4 2023 Earnings Call Transcript

There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Alkermes (ALKS – Research Report), Opko Health (OPK ...

Analysts Offer Insights on Healthcare Companies: Alkermes (ALKS), Opko Health (OPK) and Leafly Holdings, Inc. (LFLY)

SLDP, SGML and SMR are among premarket gainers

Wall Street is positive on Leafly Holdings Inc (LFLY). On average, analysts give the stock a Buy rating. The average price target is $60, which means analysts expect the stock to increase by 1740.49% over the next twelve months.That average ranking earns the stock an Analyst Rating of 25, which is better than 25% of stocks

Analyst Rating: Will Leafly Holdings Inc (LFLY) Stock Outperform the Market?

New York judge strikes down state's marijuana marketing laws

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
The trading week starts with a dive into the biggest pre-market stock movers worth keeping tabs on for Monday morning!



Moving stocks this morning are public offerings, delisting notices, dividends and more.



Let&rsquo;s get into that news below!



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li>Hub Cyber Security (NASDAQ:<a href="https://investorplace.com/stock-quotes/hubc-stock-quote/">HUBC</a>) stock is rocketing more than 44% alongside heavy pre-market trading.</li>



<li>Longeveron (NASDAQ:<a href="https://investorplace.com/stock-quotes/lgvn-stock-quote/">LGVN</a>) shares are soaring over 44% after <a href="https://www.nasdaq.com/press-release/longeveron-announces-closing-of-%245.2-million-public-offering-2024-04-11">closing a public offering</a> <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318233823&amp;type=PDF&amp;symbol=LGVN&amp;cdn=a770dc64078369c76023bc924ed74b50&amp;companyName=Longeveron+Inc.&amp;formType=4&amp;formDescription=Statement+of+changes+in+beneficial+ownership+of+securities&amp;dateFiled=2024-04-12">and insider buying</a>.</li>



<li>Allarity Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/allr-stock-quote/">ALLR</a>) stock is surging more than 37% after <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318232384&amp;type=PDF&amp;symbol=ALLR&amp;cdn=b9395315130771ba262873e0f9f45c59&amp;companyName=Allarity+Therapeutics+Inc.&amp;formType=424B5&amp;formDescription=Prospectus+%5BRule+424%28b%29%285%29%5D&amp;dateFiled=2024-04-12">amending its sales agreement</a>.</li>



<li>Snap One (NASDAQ:<a href="https://investorplace.com/stock-quotes/snpo-stock-quote/">SNPO</a>) shares are rising over 29% after announcing <a href="https://www.nasdaq.com/press-release/resideo-to-acquire-snap-one-to-expand-presence-in-smart-living-products-and">an acquisition deal</a>.</li>



<li>Piedmont Lithium (NASDAQ:<a href="https://investorplace.com/stock-quotes/pll-stock-quote/">PLL</a>) stock is gaining more than 23% after getting <a href="https://www.nasdaq.com/press-release/piedmont-lithium-receives-mining-permit-approval-for-carolina-lithium-2024-04-15">mining permit approval</a>.</li>



<li>SuperCom (NASDAQ:<a href="https://investorplace.com/stock-quotes/spcb-stock-quote/">SPCB</a>) shares are rising over 16% with incredibly strong early morning movement.</li>



<li>Leafly (NASDAQ:<a href="https://investorplace.com/stock-quotes/lfly-stock-quote/">LFLY</a>) stock is flying more than 16% higher after <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318232734&amp;type=PDF&amp;symbol=LFLY&amp;cdn=fac5fc6f5ecd43707f276b2f37608568&amp;companyName=Leafly+Holdings+Inc.&amp;formType=8-K&amp;formDescription=Current+report+pursuant+to+Section+13+or+15%28d%29&amp;dateFiled=2024-04-12">falling Friday on delisting news</a>.</li>



<li>Allakos (NASDAQ:<a href="https://investorplace.com/stock-quotes/allk-stock-quote/">ALLK</a>) shares are increasing over 15% without any clear news this morning.</li>



<li>Medical Properties Trust (NYSE:<a href="https://investorplace.com/stock-quotes/mpw-stock-quote/">MPW</a>) stock is jumping more than 14% after <a href="https://finance.yahoo.com/news/medical-properties-trust-declares-regular-202000224.html">declaring its quarterly dividend</a>.</li>



<li>Marine Petroleum Trust (NASDAQ:<a href="https://investorplace.com/stock-quotes/marps-stock-quote/">MARPS</a>) shares are up over 13% despite a lack of news today.</li>
</ol><h2>10 Top Losers</h2>



<ol><li>AudioEye (NASDAQ:<a href="https://investorplace.com/stock-quotes/aeye-stock-quote/">AEYE</a>) stock is plummeting more than 34% on Monday morning.</li>



<li>Neumora Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/nmra-stock-quote/">NMRA</a>) shares are diving over 23% after <a href="https://www.nasdaq.com/press-release/neumora-therapeutics-announces-clinical-hold-of-phase-1-nmra-266-study-2024-04-15">announcing a clinical hold</a> on a Phase 1 trial.</li>



<li>NextPlat (NASDAQ:<a href="https://investorplace.com/stock-quotes/nxpl-stock-quote/">NXPL</a>) stock is tumbling more than 19% <a href="https://investorplace.com/2024/04/why-is-nextplat-nxpl-stock-up-34-today/">following a Friday rally</a>.</li>



<li>Mobile Global Esports (NASDAQ:<a href="https://investorplace.com/stock-quotes/mgam-stock-quote/">MGAM</a>) shares are taking an over 18% beating <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318232971&amp;type=PDF&amp;symbol=MGAM&amp;cdn=16491c2c834a89973f90cd665be062a9&amp;companyName=Mobile+Global+Esports+Inc.&amp;formType=8-K&amp;formDescription=Current+report+pursuant+to+Section+13+or+15%28d%29&amp;dateFiled=2024-04-12">on delisting news</a>.</li>



<li>IM Cannabis (NASDAQ:<a href="https://investorplace.com/stock-quotes/imcc-stock-quote/">IMCC</a>) stock is sliding more than 17% without any obvious news to report.</li>



<li>Beneficient (NASDAQ:<a href="https://investorplace.com/stock-quotes/benf-stock-quote/">BENF</a>) shares are dropping over 17% on Monday morning.</li>



<li>Tracon Pharma (NASDAQ:<a href="https://investorplace.com/stock-quotes/tcon-stock-quote/">TCON</a>) stock is decreasing more than 13% after warning investors it only has enough cash to operate <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318233346&amp;type=PDF&amp;symbol=TCON&amp;cdn=d702801afb8d5bee35038dce1c2e4efc&amp;companyName=TRACON+Pharmaceuticals+Inc.&amp;formType=8-K&amp;formDescription=Current+report+pursuant+to+Section+13+or+15%28d%29&amp;dateFiled=2024-04-12">until late Q3 2024</a>.</li>



<li>Cyngn (NASDAQ:<a href="https://investorplace.com/stock-quotes/cyn-stock-quote/">CYN</a>) shares are falling over 13% on a <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318233680&amp;type=PDF&amp;symbol=CYN&amp;cdn=5af092c6fdb596a429dfa66036eafcc1&amp;companyName=Cyngn+Inc.&amp;formType=S-1&amp;formDescription=Registration+statement+under+Securities+Act+of+1933&amp;dateFiled=2024-04-12">proposed public offering</a>.</li>



<li>OncoCyte (NASDAQ:<a href="https://investorplace.com/stock-quotes/ocx-stock-quote/">OCX</a>) stock is slipping more than 12% alongside its <a href="https://finance.yahoo.com/news/oncocyte-reports-full-2023-financial-100000423.html">latest earnings report</a>.</li>



<li>Shuttle Pharmaceuticals (NASDAQ:<a href="https://investorplace.com/stock-quotes/shph-stock-quote/">SHPH</a>) shares close out our pre-market stock movers down 12% this morning.</li>
</ol>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/04/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-monday-april-15th/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

ACRDF

ACRHF

AEYE

ALKS

ALLG

ALLK

ALLR

BENF

DOMA

HSAI

HUBC

IMCC

LFLYW

LGVN

MARPS

MESO

MGAM

NMRA

NXPL

SGML

SHPH

SLDP

SNPO

SPCB

TCON

VSTE

Press Releases

Leafly Named Best B2C Cannabis Technology Platform

Leafly Regains Compliance with Nasdaq Minimum Bid Price Requirement

Leafly to Announce Third Quarter 2023 Financial Results on November 9, 2023

Leafly Celebrates 3rd Annual International Budtenders Day

Leafly Holdings, Inc. Reports Third Quarter 2023 Financial Results

Leafly 2023 Cannabis Strain of the Year is "Permanent Marker"

Leafly to Announce Fourth Quarter and Fiscal Year 2023 Financial Results on March 28, 2024

Leafly Holdings, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results

Leafly Holdings, Inc. Announces Appointment of Two Cannabis Industry Veterans to Its Board

Leafly to Announce First Quarter 2024 Financial Results on May 9, 2024

LOWLF

Antelope Enterprise Holdings Limited - Class A Ordinary Shares

Antelope Ent Hldgs

The Arena Group Holdings, Inc. Common Stock

Arena Group Holdings

Cheer Holding

Fangdd Network Group Ltd. - American Depositary Shares

Fangdd Network Group

Phoenix New Media Limited American Depositary Shares, each representing 48 Class A ordinary shares.